CancerDrs

Colorectal Cancer clinical trials in Rhode Island

3 actively recruiting colorectal cancer trials at 1 site across Rhode Island.

Data from ClinicalTrials.gov · last refreshed

Phase 2 Recruiting Academic/Other

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

BrUOG-430 is a prospective, single-arm, phase 2 trial evaluating yttrium-90 radioembolization in combination with capecitabine and atezolizumab for the treatment of unresectable colorectal cancer liver metastases in individuals who have be…

Sponsor: Brown University
NCT ID: NCT06555133
Sites in Rhode Island:
  • Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals Providence, Rhode Island, United States, 02903 Contact: — Providence, Rhode Island
Phase 1 Recruiting NIH

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

The purpose of this phase I trial is to test the safety and cancer preventive effects of different doses of ONC201 in people with familial adenomatous polyposis (FAP) or a history of multiple polyps. People with familial adenomatous polypo…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05630794
Sites in Rhode Island:
  • Rhode Island Hospital — Providence, Rhode Island
Phase 1 Recruiting Academic/Other

TLR9 Immunotherapy for Peritoneal Carcinomatosis

The goal of this clinical trial is to determine the safety and efficacy of of ACM-CpG for inoperable peritoneal metastases or malignant ascites. The main questions it aims to answer are: • To determine the safety and maximum tolerated dose…

Sponsor: Brown University
NCT ID: NCT07658196
Sites in Rhode Island:
  • Rhode Island and the Miriam Hospitals (Brown University Health) — Providence, Rhode Island

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01